Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0782
    -0.0012 (-0.11%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2627
    +0.0005 (+0.04%)
     
  • USD/JPY

    151.3320
    -0.0400 (-0.03%)
     
  • Bitcoin USD

    69,966.78
    -892.95 (-1.26%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Today's Research Reports on Trending Tickers: Dr. Reddy's Laboratories and AbbVie

NEW YORK, NY / ACCESSWIRE / December 19, 2018 / U.S. markets finished modestly higher on a very volatile trading day on Tuesday. The volatility was probably due to the market’s anxiety over the uncertainty in U.S.-China trade relation, growing fears of a government shutdown, a slide in oil prices and fears of the Federal Reserve’s tightening of monetary policy. The Dow Jones Industrial Average gained 0.35 percent to close at 23,675.64, while the S&P 500 Index increased 0.01 percent to close at 2,546.16. The Nasdaq Composite Index climbed 0.45 percent to close at 6,783.91.

The Chief Investment Strategist of Key Private Bank, Bruce McCain said, "I think it's anxiety about slowing economic growth and [traders] want assurance that someone's going to do something."

"Clearly, it's a time of uncertainly both here and overseas, but given the strength of the economy, it's going to take some time until the economic backdrop supports a bear market. It's about managing your anxiety and waiting long enough to find out that, hopefully, the news isn't so bad," he added.

The Market Edge Initiates Coverage on:

Dr. Reddy's Laboratories Ltd.
https://marketedgereport.com/report/RDY/

AbbVie Inc.
https://marketedgereport.com/report/ABBV/

Dr. Reddy's Laboratories’ stock jumped 3.18% Tuesday, to close the day at $37.32. The stock recorded a trading volume of 222,848 shares, which was below its three months average volume of 286,568 shares. In the last year, Dr. Reddy's Laboratories’ shares have traded in a range of 28.13 - 39.96. The share price has gained 32.67% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $35.60 is above its 200-day moving average of $33.78. Shares of the company are trading at a Price to Earnings ratio of 26.58. Shares of Dr. Reddy's Laboratories have gained roughly 6.87 percent in the past month and are down 0.64 percent year-to-date.

Access The Market Edge's Dr. Reddy's Laboratories Ltd. Research Report:
https://marketedgereport.com/report/RDY/

On Tuesday, shares of AbbVie recorded a trading volume of 5,288,570 shares, which was below the three months average volume of 6,523,082 shares. The stock ended the day 1.59% lower at $83.58. The share price has fallen 33.59% from its 52 week high with a 52 week trading range of 77.50 - 125.86. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $87.21 is below its 200-day moving average of $92.52. Shares of the company are trading at a Price to Earnings ratio of 17.46. Shares of AbbVie have fallen roughly 8.69 percent in the past month and are down 13.58 percent year-to-date.

Access The Market Edge's AbbVie Inc. Research Report:
https://marketedgereport.com/report/ABBV/

Our Actionable Research on Dr. Reddy's Laboratories Ltd. (NYSE:RDY) and AbbVie Inc. (NYSE:ABBV) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: The Market Edge

Advertisement